195060-56-1

Basic information

• Product Name: 3-iodo-4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-allyloxy]-benzoic acid methyl ester
• Synonyms: 3-iodo-4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-allyloxy]-benzoic acid methyl ester
• CAS NO: 195060-56-1
• Molecular Weight: 504.408
• Mol File: 195060-56-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-iodo-4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-allyloxy]-benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-iodo-4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-allyloxy]-benzoic acid methyl ester(195060-56-1)
• EPA Substance Registry System: 3-iodo-4-[2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-allyloxy]-benzoic acid methyl ester(195060-56-1)

Safety Data

• Hazardous Substances Data: 195060-56-1(Hazardous Substances Data)

Upstream product

• 1779-49-3 Methyltriphenylphosphonium bromide 
• 195060-55-0 3-iodo-4-[2-oxo-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-ethoxy]benzoic acid methyl ester 
• 132392-28-0 2-bromo-1-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethan-1-one 
• 15126-06-4 methyl 3-iodo-4-hydroxybenzoate 

Relevant articles and documents

New synthetic retinoids obtained by palladium-catalyzed tandem cyclisation-hydride capture process

A new series of conformationally restricted retinoids (3-aryl-3-methyl- 2,3-dihydrobenzofurans) have been prepared through a palladium-catalyzed tandem cyclisation-hydride capture. The use of enantiopure BINAP-Pd catalyst allowed asymmetric synthesis of bioactive molecules.